Autoimmune Technologies LLC is a biomedical company spun out of Tulane Universityâs School of Medicine developing medical diagnostic tests, exploring disease mechanisms, and investigating therapies for viral diseases and autoimmune diseases. With many of the company's products based on proprietary technologies licensed from Tulane University School of Medicine and based on breakthrough research discoveries, the firm is organized around develop anti-viral drugs designed to prevent viral particles from fusing with their targeting cells. The company is developing FF-3, which is an influenza drug with a new method of action; as well as a blood test to aid in the diagnosis of Lassa fever; a blood test to aid in the diagnosis of fibromyalgia, a blood test to aid in the diagnosis of systemic lupus erythematosus, Sjögren's syndrome, juvenile rheumatoid arthritis and Grave's disease; and a blood test to detect the presence of the pro-viral DNA of an inherited retrovirus that appears to be associated with most cases of breast cancer. Work on Gulf War Syndrome and other disorders is also underwa
